Page last updated: 2024-11-05

pinacolone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pinacolone: a metabolite of soman [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3,3-dimethylbutan-2-one : A methyl ketone that is butane substituted by an oxo group at position 2 and two methyl groups at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6416
CHEMBL ID3183565
CHEBI ID197349
SCHEMBL ID43148
MeSH IDM0225579

Synonyms (63)

Synonym
3,3-dimethylbutan-2-one, methyl t-butyl ketone, pinacolin, pinacolone, tert-butyl methyl ketone
methyltert-butyl ketone
pinakolin
nsc 935
brn 1209331
einecs 200-920-4
hsdb 5210
methyl t-butyl ketone
ketone, t-butyl methyl
ai3-03075
pinakolin [german]
1,1,1-trimethylacetone
t-butyl methyl ketone
2-butanone, 3,3-dimethyl-
3,3-dimethylbutan-2-one
inchi=1/c6h12o/c1-5(7)6(2,3)4/h1-4h
pinacolone
wln: 1x1&1&v1
ketone, tert-butyl methyl
pinacolin
2-butanone,3-dimethyl-
3,3-dimethylbutanone
3,3-dimethyl-2-butanone
2,2-dimethylbutanone
2,2-dimethyl-3-butanone
tert-butyl methyl ketone
75-97-8
methyl tert-butyl ketone
nsc935
1,1-trimethylacetone
pinacoline
nsc-935
3,3-dimethyl-2-butanone, 98%
D0692
AKOS000118891
FT-0658979
1,1-dimethylethyl methyl ketone
methyl-t-butylketone
CHEBI:197349
alpha,alpha,alpha--trimethylacetone
STL134907
NCGC00248508-01
dtxcid801752
cas-75-97-8
tox21_200060
dtxsid5021752 ,
NCGC00257614-01
3,3-dimethyl-butan-2-one
unii-3u1aag3528
3u1aag3528 ,
pinacolone [mi]
3,3-dimethyl-2-butanone [hsdb]
tert-butyl-methyl ketone
t-butylmethylketone
SCHEMBL43148
tert-c4h9coch3
a,a,a-trimethylacetone
W-104380
CHEMBL3183565
mfcd00008846
GEO-02795
Q222983
FS-4025
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
methyl ketoneA ketone of formula RC(=O)CH3 (R =/= H).
dialkyl ketone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency28.36460.006038.004119,952.5996AID1159521
retinoid X nuclear receptor alphaHomo sapiens (human)Potency25.51120.000817.505159.3239AID1159527
aryl hydrocarbon receptorHomo sapiens (human)Potency56.59480.000723.06741,258.9301AID743085
activating transcription factor 6Homo sapiens (human)Potency3.60360.143427.612159.8106AID1159516
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's1 (7.14)18.2507
2000's4 (28.57)29.6817
2010's7 (50.00)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.79 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index76.38 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]